BMJ (Clinical research ed.)
Lecanemab: Controversial Alzheimer's drug approved by Australian drugs regulator after two rejections.
Bianca Nogrady
Published: 202510.1136/bmj.r2056
No abstract available for this study.
Bianca Nogrady
No abstract available for this study.